The Georgiou Lab – Laboratory of Protein Therapeutics and Applied Immunology

The Georgiou Lab

Enzyme Safely Starves Cancer Cells in Preclinical Study
AUSTIN, Texas — A research team led by scientists at The University of Texas Austin has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of Nature Medicine.
Flu Vaccine’s Effectiveness Can Be Improved, New Findings Suggest
The four-year project was led by George Georgiou, a professor in the Cockrell School of Engineering and in the College of Natural Sciences.

Research

Find out more about the Research projects currently active in the Georgiou group.

Highlights

Find out about features and highlights of the groundbreaking research from the Georgiou lab.

Contact

Have questions? See here for the methods of getting in contact with the Georgiou lab.